Publication | Open Access
Prevention of heterotopic ossification after total hip replacement: A prospective comparison of indomethacin and salmon calcitonin in 60 patients
23
Citations
15
References
2001
Year
Salmon CalcitoninBone DiseaseHip ArthroplastyOsteopathyProspective Consecutive StudyTotal Hip ReplacementOsteoarthritisProspective ComparisonCalcitonin GroupSurgeryOsteoporosisProsthetic Joint InfectionsJoint ReplacementMedicineOrthopaedic SurgeryNon-operative Treatment
We did a prospective consecutive study of prophylaxis for heterotopic ossification (HO) comparing indomethacin (100 mg/day) and salmon calcitonin (3 MRC-U/kg/day) for 14 days. Each group consisted of 30 patients. 19 patients in the indomethacin group and 2 in the calcitonin group developed HO. We conclude that use of calcitonin in the prophylaxis of HO after total hip replacement is more effective than indomethacin.
| Year | Citations | |
|---|---|---|
1973 | 2.8K | |
1975 | 334 | |
1997 | 150 | |
1992 | 109 | |
1995 | 102 | |
1973 | 80 | |
1974 | 72 | |
1979 | 67 | |
1986 | 65 | |
1988 | 51 |
Page 1
Page 1